MicroRNA Market Report

Global and Regional MicroRNA Market Details Research Report 2021-2026

  • POSTDATE：Jun 24, 2021
  • PAGES：219
  • REPORT CODE：GMM714801
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global MicroRNA Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive MicroRNA market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global MicroRNA market.

    By Player:

    • BioVendor

    • Abcam

    • NanoString Technologies

    • Kaneka Corporation

    • New England Biolabs

    • Sigma Aldrich

    • Miltenyi Biotec

    • Bio-Rad

    • Meridian Life Science

    • Thermo Fisher Scientific

    • Illumina

    • Agilent

    • Roche

    • Rosetta Genomics

    • HTG Molecular Diagnostics

    • Promega Corporation

    • Dharmacon

    • GeneCopoeia

    • Qiagen

    By Type:

    • PCR-based Assay

    • miRNA Arrays

    • Next Generation Sequencing (NGS)

    • Immunoassay

    By End-User:

    • Diagnostic Centers

    • Academic and Research Institutes

    • Biopharmaceutical Companies

    • Contract Research Organizations

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 MicroRNA Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global MicroRNA Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global MicroRNA Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global MicroRNA Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global MicroRNA Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers MicroRNA Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 BioVendor

      • 3.1.1 BioVendor - Company Business Overview

      • 3.1.2 BioVendor - Company Financial Performance

      • 3.1.3 BioVendor - Company Financial Performance of MicroRNA

      • 3.1.4 MicroRNA Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Abcam

      • 3.2.1 Abcam - Company Business Overview

      • 3.2.2 Abcam - Company Financial Performance

      • 3.2.3 Abcam - Company Financial Performance of MicroRNA

      • 3.2.4 MicroRNA Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 NanoString Technologies

      • 3.3.1 NanoString Technologies - Company Business Overview

      • 3.3.2 NanoString Technologies - Company Financial Performance

      • 3.3.3 NanoString Technologies - Company Financial Performance of MicroRNA

      • 3.3.4 MicroRNA Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Kaneka Corporation

      • 3.4.1 Kaneka Corporation - Company Business Overview

      • 3.4.2 Kaneka Corporation - Company Financial Performance

      • 3.4.3 Kaneka Corporation - Company Financial Performance of MicroRNA

      • 3.4.4 MicroRNA Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 New England Biolabs

      • 3.5.1 New England Biolabs - Company Business Overview

      • 3.5.2 New England Biolabs - Company Financial Performance

      • 3.5.3 New England Biolabs - Company Financial Performance of MicroRNA

      • 3.5.4 MicroRNA Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Sigma Aldrich

      • 3.6.1 Sigma Aldrich - Company Business Overview

      • 3.6.2 Sigma Aldrich - Company Financial Performance

      • 3.6.3 Sigma Aldrich - Company Financial Performance of MicroRNA

      • 3.6.4 MicroRNA Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Miltenyi Biotec

      • 3.7.1 Miltenyi Biotec - Company Business Overview

      • 3.7.2 Miltenyi Biotec - Company Financial Performance

      • 3.7.3 Miltenyi Biotec - Company Financial Performance of MicroRNA

      • 3.7.4 MicroRNA Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Bio-Rad

      • 3.8.1 Bio-Rad - Company Business Overview

      • 3.8.2 Bio-Rad - Company Financial Performance

      • 3.8.3 Bio-Rad - Company Financial Performance of MicroRNA

      • 3.8.4 MicroRNA Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Meridian Life Science

      • 3.9.1 Meridian Life Science - Company Business Overview

      • 3.9.2 Meridian Life Science - Company Financial Performance

      • 3.9.3 Meridian Life Science - Company Financial Performance of MicroRNA

      • 3.9.4 MicroRNA Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Thermo Fisher Scientific

      • 3.10.1 Thermo Fisher Scientific - Company Business Overview

      • 3.10.2 Thermo Fisher Scientific - Company Financial Performance

      • 3.10.3 Thermo Fisher Scientific - Company Financial Performance of MicroRNA

      • 3.10.4 MicroRNA Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Illumina

      • 3.11.1 Illumina - Company Business Overview

      • 3.11.2 Illumina - Company Financial Performance

      • 3.11.3 Illumina - Company Financial Performance of MicroRNA

      • 3.11.4 MicroRNA Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Agilent

      • 3.12.1 Agilent - Company Business Overview

      • 3.12.2 Agilent - Company Financial Performance

      • 3.12.3 Agilent - Company Financial Performance of MicroRNA

      • 3.12.4 MicroRNA Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Roche

      • 3.13.1 Roche - Company Business Overview

      • 3.13.2 Roche - Company Financial Performance

      • 3.13.3 Roche - Company Financial Performance of MicroRNA

      • 3.13.4 MicroRNA Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Rosetta Genomics

      • 3.14.1 Rosetta Genomics - Company Business Overview

      • 3.14.2 Rosetta Genomics - Company Financial Performance

      • 3.14.3 Rosetta Genomics - Company Financial Performance of MicroRNA

      • 3.14.4 MicroRNA Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 HTG Molecular Diagnostics

      • 3.15.1 HTG Molecular Diagnostics - Company Business Overview

      • 3.15.2 HTG Molecular Diagnostics - Company Financial Performance

      • 3.15.3 HTG Molecular Diagnostics - Company Financial Performance of MicroRNA

      • 3.15.4 MicroRNA Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Promega Corporation

      • 3.16.1 Promega Corporation - Company Business Overview

      • 3.16.2 Promega Corporation - Company Financial Performance

      • 3.16.3 Promega Corporation - Company Financial Performance of MicroRNA

      • 3.16.4 MicroRNA Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 Dharmacon

      • 3.17.1 Dharmacon - Company Business Overview

      • 3.17.2 Dharmacon - Company Financial Performance

      • 3.17.3 Dharmacon - Company Financial Performance of MicroRNA

      • 3.17.4 MicroRNA Product Benchmarking

      • 3.17.5 Strategic Initiatives

    • 3.18 GeneCopoeia

      • 3.18.1 GeneCopoeia - Company Business Overview

      • 3.18.2 GeneCopoeia - Company Financial Performance

      • 3.18.3 GeneCopoeia - Company Financial Performance of MicroRNA

      • 3.18.4 MicroRNA Product Benchmarking

      • 3.18.5 Strategic Initiatives

    • 3.19 Qiagen

      • 3.19.1 Qiagen - Company Business Overview

      • 3.19.2 Qiagen - Company Financial Performance

      • 3.19.3 Qiagen - Company Financial Performance of MicroRNA

      • 3.19.4 MicroRNA Product Benchmarking

      • 3.19.5 Strategic Initiatives

    4 Global MicroRNA Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global MicroRNA Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of PCR-based Assay 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of miRNA Arrays 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Next Generation Sequencing (NGS) 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Immunoassay 2016-2021

    • 4.3 Global MicroRNA Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of PCR-based Assay 2016-2021

      • 4.3.2 Global Sales and Growth Rate of miRNA Arrays 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Next Generation Sequencing (NGS) 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Immunoassay 2016-2021

    • 4.4 Global MicroRNA Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global MicroRNA Market Sales and Market Share by Types (Forecast)

    • 4.6 Global MicroRNA Market Price By Type from 2016 to 2026

    5 Global MicroRNA Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of MicroRNA

    • 5.2 Global MicroRNA Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Diagnostic Centers 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Academic and Research Institutes 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Biopharmaceutical Companies 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Contract Research Organizations 2016-2021

    • 5.3 Global MicroRNA Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Diagnostic Centers 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Academic and Research Institutes 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Biopharmaceutical Companies 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Contract Research Organizations 2016-2021

    • 5.4 Global MicroRNA Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global MicroRNA Market Sales and Market Share by Application (Forecast)

    6 Global MicroRNA Market Segment Analysis (Geography Level)

    • 6.1 Global MicroRNA Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global MicroRNA Market Sales and Market Share by Geography (Historical)

    • 6.3 Global MicroRNA Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global MicroRNA Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in MicroRNA Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in MicroRNA Market from 2016 to 2020

    7. North America MicroRNA Market Segment Analysis and Investment Attractiveness

    • 7.1 North America MicroRNA Market Segment by Countries

      • 7.1.1 North America MicroRNA Market Revenue Segment by Countries

      • 7.1.2 North America MicroRNA Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America MicroRNA Market Segment (Product Type Level)

    • 7.3 North America MicroRNA Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe MicroRNA Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe MicroRNA Market Segment by Countries

      • 8.1.1 Europe MicroRNA Market Revenue Segment by Countries

      • 8.1.2 Europe MicroRNA Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe MicroRNA Market Segment (Product Type Level)

    • 8.3 Europe MicroRNA Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia MicroRNA Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia MicroRNA Market Segment by Countries

      • 9.1.1 Asia MicroRNA Market Revenue Segment by Countries

      • 9.1.2 Asia MicroRNA Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia MicroRNA Market Segment (Product Type Level)

    • 9.3 Asia MicroRNA Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America MicroRNA Market Segment Analysis and Investment Attractiveness

    • 10.1 South America MicroRNA Market Segment by Countries

      • 10.1.1 South America MicroRNA Market Revenue Segment by Countries

      • 10.1.2 South America MicroRNA Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America MicroRNA Market Segment (Product Type Level)

    • 10.3 South America MicroRNA Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East MicroRNA Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East MicroRNA Market Segment by Countries

      • 11.1.1 Middle East MicroRNA Market Revenue Segment by Countries

      • 11.1.2 Middle East MicroRNA Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East MicroRNA Market Segment (Product Type Level)

    • 11.3 Middle East MicroRNA Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa MicroRNA Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa MicroRNA Market Segment by Countries

      • 12.1.1 Africa MicroRNA Market Revenue Segment by Countries

      • 12.1.2 Africa MicroRNA Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa MicroRNA Market Segment (Product Type Level)

    • 12.3 Africa MicroRNA Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania MicroRNA Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania MicroRNA Market Segment by Countries

      • 13.1.1 Oceania MicroRNA Market Revenue Segment by Countries

      • 13.1.2 Oceania MicroRNA Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania MicroRNA Market Segment (Product Type Level)

    • 13.3 Oceania MicroRNA Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 MicroRNA Production Analysis

      • 14.2.1 Manufacturing Cost Structure of MicroRNA

      • 14.2.2 Manufacturing Process Analysis of MicroRNA

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of MicroRNA Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 MicroRNA Industry Market Status, Pre-COVID-19

      • 15.5.3 MicroRNA Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 MicroRNA Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure MicroRNA Product Picture

    • Table MicroRNA Product Definition

    • Table Study Scope by Types

    • Figure Global MicroRNA Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global MicroRNA Market Value by Application (2016 - 2026)

    • Figure Global MicroRNA Market Size and Growth Rate from 2016 to 2026

    • Table Global MicroRNA Production Capacity by Manufacturers (2016-2021)

    • Table Global MicroRNA Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global MicroRNA Revenue by Manufacturers (2016-2021)

    • Table Global MicroRNA Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers MicroRNA Plant Distribution and Sales Country

    • Table BioVendor - Company Business Overview

    • Figure BioVendor Total Revenue from 2018 to 2020

    • Table BioVendor Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BioVendor Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of BioVendor

    • Table MicroRNA Product Benchmarking

    • Table Abcam - Company Business Overview

    • Figure Abcam Total Revenue from 2018 to 2020

    • Table Abcam Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Abcam Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Abcam

    • Table MicroRNA Product Benchmarking

    • Table NanoString Technologies - Company Business Overview

    • Figure NanoString Technologies Total Revenue from 2018 to 2020

    • Table NanoString Technologies Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure NanoString Technologies Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of NanoString Technologies

    • Table MicroRNA Product Benchmarking

    • Table Kaneka Corporation - Company Business Overview

    • Figure Kaneka Corporation Total Revenue from 2018 to 2020

    • Table Kaneka Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Kaneka Corporation Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Kaneka Corporation

    • Table MicroRNA Product Benchmarking

    • Table New England Biolabs - Company Business Overview

    • Figure New England Biolabs Total Revenue from 2018 to 2020

    • Table New England Biolabs Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure New England Biolabs Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of New England Biolabs

    • Table MicroRNA Product Benchmarking

    • Table Sigma Aldrich - Company Business Overview

    • Figure Sigma Aldrich Total Revenue from 2018 to 2020

    • Table Sigma Aldrich Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sigma Aldrich Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Sigma Aldrich

    • Table MicroRNA Product Benchmarking

    • Table Miltenyi Biotec - Company Business Overview

    • Figure Miltenyi Biotec Total Revenue from 2018 to 2020

    • Table Miltenyi Biotec Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Miltenyi Biotec Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Miltenyi Biotec

    • Table MicroRNA Product Benchmarking

    • Table Bio-Rad - Company Business Overview

    • Figure Bio-Rad Total Revenue from 2018 to 2020

    • Table Bio-Rad Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bio-Rad Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Bio-Rad

    • Table MicroRNA Product Benchmarking

    • Table Meridian Life Science - Company Business Overview

    • Figure Meridian Life Science Total Revenue from 2018 to 2020

    • Table Meridian Life Science Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Meridian Life Science Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Meridian Life Science

    • Table MicroRNA Product Benchmarking

    • Table Thermo Fisher Scientific - Company Business Overview

    • Figure Thermo Fisher Scientific Total Revenue from 2018 to 2020

    • Table Thermo Fisher Scientific Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Thermo Fisher Scientific Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table MicroRNA Product Benchmarking

    • Table Illumina - Company Business Overview

    • Figure Illumina Total Revenue from 2018 to 2020

    • Table Illumina Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Illumina Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Illumina

    • Table MicroRNA Product Benchmarking

    • Table Agilent - Company Business Overview

    • Figure Agilent Total Revenue from 2018 to 2020

    • Table Agilent Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Agilent Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Agilent

    • Table MicroRNA Product Benchmarking

    • Table Roche - Company Business Overview

    • Figure Roche Total Revenue from 2018 to 2020

    • Table Roche Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Roche Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Roche

    • Table MicroRNA Product Benchmarking

    • Table Rosetta Genomics - Company Business Overview

    • Figure Rosetta Genomics Total Revenue from 2018 to 2020

    • Table Rosetta Genomics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Rosetta Genomics Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Rosetta Genomics

    • Table MicroRNA Product Benchmarking

    • Table HTG Molecular Diagnostics - Company Business Overview

    • Figure HTG Molecular Diagnostics Total Revenue from 2018 to 2020

    • Table HTG Molecular Diagnostics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure HTG Molecular Diagnostics Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of HTG Molecular Diagnostics

    • Table MicroRNA Product Benchmarking

    • Table Promega Corporation - Company Business Overview

    • Figure Promega Corporation Total Revenue from 2018 to 2020

    • Table Promega Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Promega Corporation Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Promega Corporation

    • Table MicroRNA Product Benchmarking

    • Table Dharmacon - Company Business Overview

    • Figure Dharmacon Total Revenue from 2018 to 2020

    • Table Dharmacon Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Dharmacon Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Dharmacon

    • Table MicroRNA Product Benchmarking

    • Table GeneCopoeia - Company Business Overview

    • Figure GeneCopoeia Total Revenue from 2018 to 2020

    • Table GeneCopoeia Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GeneCopoeia Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of GeneCopoeia

    • Table MicroRNA Product Benchmarking

    • Table Qiagen - Company Business Overview

    • Figure Qiagen Total Revenue from 2018 to 2020

    • Table Qiagen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Qiagen Sales and Growth Rate Analysis of MicroRNA

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table MicroRNA Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global MicroRNA Market Revenue by Types (Historical)

    • Table Global MicroRNA Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of PCR-based Assay 2016-2021

    • Figure Global Revenue and Growth Rate of miRNA Arrays 2016-2021

    • Figure Global Revenue and Growth Rate of Next Generation Sequencing (NGS) 2016-2021

    • Figure Global Revenue and Growth Rate of Immunoassay 2016-2021

    • Table Global MicroRNA Market Sales by Types (Historical)

    • Table Global MicroRNA Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of PCR-based Assay 2016-2021

    • Figure Global Sales and Growth Rate of miRNA Arrays 2016-2021

    • Figure Global Sales and Growth Rate of Next Generation Sequencing (NGS) 2016-2021

    • Figure Global Sales and Growth Rate of Immunoassay 2016-2021

    • Table Global MicroRNA Market Revenue by Types (Forecast)

    • Table Global MicroRNA Market Revenue Market Share by Types (Forecast)

    • Table Global MicroRNA Market Sales by Types (Forecast)

    • Table Global MicroRNA Market Sales Market Share by Types (Forecast)

    • Figure Global MicroRNA Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for MicroRNA

    • Table Global MicroRNA Market Revenue by Application (Historical)

    • Table Global MicroRNA Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Diagnostic Centers 2016-2021

    • Figure Global Revenue and Growth Rate of Academic and Research Institutes 2016-2021

    • Figure Global Revenue and Growth Rate of Biopharmaceutical Companies 2016-2021

    • Figure Global Revenue and Growth Rate of Contract Research Organizations 2016-2021

    • Table Global MicroRNA Market Sales by Application (Historical)

    • Table Global MicroRNA Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Diagnostic Centers 2016-2021

    • Figure Global Sales and Growth Rate of Academic and Research Institutes 2016-2021

    • Figure Global Sales and Growth Rate of Biopharmaceutical Companies 2016-2021

    • Figure Global Sales and Growth Rate of Contract Research Organizations 2016-2021

    • Table Global MicroRNA Market Revenue by Application (Forecast)

    • Table Global MicroRNA Market Revenue Market Share by Application (Forecast)

    • Table Global MicroRNA Market Sales by Application (Forecast)

    • Table Global MicroRNA Market Sales Market Share by Application (Forecast)

    • Table Global MicroRNA Market Revenue by Geography (Historical)

    • Table Global MicroRNA Market Revenue Market Share by Geography (Historical)

    • Figure Global MicroRNA Revenue Market Share by Geography in 2020

    • Table Global MicroRNA Market Sales by Geography (Historical)

    • Table Global MicroRNA Market Sales Market Share by Geography (Historical)

    • Figure Global MicroRNA Sales Market Share by Geography in 2020

    • Table Global MicroRNA Market Revenue by Geography (Forecast)

    • Table Global MicroRNA Market Revenue Market Share by Geography (Forecast)

    • Table Global MicroRNA Market Sales by Geography (Forecast)

    • Table Global MicroRNA Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America MicroRNA Revenue by Countries from 2016 to 2026

    • Table North America MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure North America MicroRNA Revenue Market Share by Major Countries in 2020

    • Table North America MicroRNA Sales by Countries from 2016 to 2026

    • Table North America MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure North America MicroRNA Sales Market Share by Major Countries in 2020

    • Figure USA MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure USA MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Canada MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table North America MicroRNA Sales by Types from 2016 to 2026

    • Table North America MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table North America MicroRNA Value by Types from 2016 to 2026

    • Table North America MicroRNA Value Market Share by Types from 2016 to 2026

    • Table North America MicroRNA Sales by Application from 2016 to 2026

    • Table North America MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table North America MicroRNA Value by Application from 2016 to 2026

    • Table North America MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Europe MicroRNA Revenue by Countries from 2016 to 2026

    • Table Europe MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe MicroRNA Revenue Market Share by Major Countries in 2020

    • Table Europe MicroRNA Sales by Countries from 2016 to 2026

    • Table Europe MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure Europe MicroRNA Sales Market Share by Major Countries in 2020

    • Figure Germany MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Germany MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure France MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure France MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Italy MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Russia MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Spain MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Poland MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Austria MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table Europe MicroRNA Sales by Types from 2016 to 2026

    • Table Europe MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table Europe MicroRNA Value by Types from 2016 to 2026

    • Table Europe MicroRNA Value Market Share by Types from 2016 to 2026

    • Table Europe MicroRNA Sales by Application from 2016 to 2026

    • Table Europe MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table Europe MicroRNA Value by Application from 2016 to 2026

    • Table Europe MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Asia MicroRNA Revenue by Countries from 2016 to 2026

    • Table Asia MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia MicroRNA Revenue Market Share by Major Countries in 2020

    • Table Asia MicroRNA Sales by Countries from 2016 to 2026

    • Table Asia MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure Asia MicroRNA Sales Market Share by Major Countries in 2020

    • Figure China MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure China MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Japan MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure India MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure India MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table Asia MicroRNA Sales by Types from 2016 to 2026

    • Table Asia MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table Asia MicroRNA Value by Types from 2016 to 2026

    • Table Asia MicroRNA Value Market Share by Types from 2016 to 2026

    • Table Asia MicroRNA Sales by Application from 2016 to 2026

    • Table Asia MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table Asia MicroRNA Value by Application from 2016 to 2026

    • Table Asia MicroRNA Value Market Share by Application from 2016 to 2026

    • Table South America MicroRNA Revenue by Countries from 2016 to 2026

    • Table South America MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure South America MicroRNA Revenue Market Share by Major Countries in 2020

    • Table South America MicroRNA Sales by Countries from 2016 to 2026

    • Table South America MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure South America MicroRNA Sales Market Share by Major Countries in 2020

    • Figure Brazil MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Chile MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table South America MicroRNA Sales by Types from 2016 to 2026

    • Table South America MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table South America MicroRNA Value by Types from 2016 to 2026

    • Table South America MicroRNA Value Market Share by Types from 2016 to 2026

    • Table South America MicroRNA Sales by Application from 2016 to 2026

    • Table South America MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table South America MicroRNA Value by Application from 2016 to 2026

    • Table South America MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Middle East MicroRNA Revenue by Countries from 2016 to 2026

    • Table Middle East MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East MicroRNA Revenue Market Share by Major Countries in 2020

    • Table Middle East MicroRNA Sales by Countries from 2016 to 2026

    • Table Middle East MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East MicroRNA Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East MicroRNA Sales by Types from 2016 to 2026

    • Table Middle East MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table Middle East MicroRNA Value by Types from 2016 to 2026

    • Table Middle East MicroRNA Value Market Share by Types from 2016 to 2026

    • Table Middle East MicroRNA Sales by Application from 2016 to 2026

    • Table Middle East MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table Middle East MicroRNA Value by Application from 2016 to 2026

    • Table Middle East MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Africa MicroRNA Revenue by Countries from 2016 to 2026

    • Table Africa MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa MicroRNA Revenue Market Share by Major Countries in 2020

    • Table Africa MicroRNA Sales by Countries from 2016 to 2026

    • Table Africa MicroRNA Sales Market Share by Countries from 2016 to 2026

      • Figure Africa MicroRNA Sales Market Share by Major Countries in 2020

    • Figure Nigeria MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table Africa MicroRNA Sales by Types from 2016 to 2026

    • Table Africa MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table Africa MicroRNA Value by Types from 2016 to 2026

    • Table Africa MicroRNA Value Market Share by Types from 2016 to 2026

    • Table Africa MicroRNA Sales by Application from 2016 to 2026

    • Table Africa MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table Africa MicroRNA Value by Application from 2016 to 2026

    • Table Africa MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Oceania MicroRNA Revenue by Countries from 2016 to 2026

    • Table Oceania MicroRNA Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania MicroRNA Revenue Market Share by Major Countries in 2020

    • Table Oceania MicroRNA Sales by Countries from 2016 to 2026

    • Table Oceania MicroRNA Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania MicroRNA Sales Market Share by Major Countries in 2020

    • Figure Australia MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Australia MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Value and Growth Rate from 2016 to 2026

    • Figure Others MicroRNA Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania MicroRNA Sales by Types from 2016 to 2026

    • Table Oceania MicroRNA Sales Market Share by Types from 2016 to 2026

    • Table Oceania MicroRNA Value by Types from 2016 to 2026

    • Table Oceania MicroRNA Value Market Share by Types from 2016 to 2026

    • Table Oceania MicroRNA Sales by Application from 2016 to 2026

    • Table Oceania MicroRNA Sales Market Share by Application from 2016 to 2026

    • Table Oceania MicroRNA Value by Application from 2016 to 2026

    • Table Oceania MicroRNA Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of MicroRNA

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of MicroRNA with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US